Global Orphan Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 20-Sep-2018
No. of pages: 136

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.

Scope of the Report:

This report focuses on the Orphan Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.

Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.

The worldwide market for Orphan Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Novartis

- Bristol-Myers Squibb

- Celgene

- Roche

- Pfizer

- Sanofi

- Alexion Pharmaceuticals

- Eli Lilly

- Novo Nordisk

- AstraZeneca

- Eisai

- Daiichi Sankyo

- Bayer

- GlaxoSmithKline

- Merck

- Johnson & Johnson

- Biogen

- Shire

- Amgen

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Oncology

- Gastrointestinal

- Pulmonary

- Neurology

- Hematology

- Cardio-vascular

- Metabolic disorders

- Endocrinology

- Infectious diseases

- Others

Market Segment by Applications, can be divided into

- Hospital Pharmacies

- Speciality Pharmacies

- Retail pharmacies

- Others

There are 15 Chapters to deeply display the global Orphan Drugs market.

Chapter 1, to describe Orphan Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Orphan Drugs, with sales, revenue, and price of Orphan Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Orphan Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Orphan Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Orphan Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Orphan Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oncology
1.2.2 Gastrointestinal
1.2.3 Pulmonary
1.2.4 Neurology
1.2.5 Hematology
1.2.6 Cardio-vascular
1.2.7 Metabolic disorders
1.2.8 Endocrinology
1.2.9 Infectious diseases
1.2.10 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Speciality Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Orphan Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Orphan Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Orphan Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Orphan Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Orphan Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Orphan Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Alexion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Orphan Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Orphan Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordisk
2.9.1 Business Overview
2.9.2 Orphan Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Orphan Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Eisai
2.11.1 Business Overview
2.11.2 Orphan Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Daiichi Sankyo
2.12.1 Business Overview
2.12.2 Orphan Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Daiichi Sankyo Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bayer
2.13.1 Business Overview
2.13.2 Orphan Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 GlaxoSmithKline
2.14.1 Business Overview
2.14.2 Orphan Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck
2.15.1 Business Overview
2.15.2 Orphan Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Johnson & Johnson
2.16.1 Business Overview
2.16.2 Orphan Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Biogen
2.17.1 Business Overview
2.17.2 Orphan Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Shire
2.18.1 Business Overview
2.18.2 Orphan Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shire Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Amgen
2.19.1 Business Overview
2.19.2 Orphan Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Orphan Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Orphan Drugs Market Analysis by Regions
4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Orphan Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Orphan Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2013-2018)
4.5 South America Orphan Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2013-2018)
5 North America Orphan Drugs by Countries
5.1 North America Orphan Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Orphan Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Orphan Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Orphan Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Orphan Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Orphan Drugs Sales and Growth Rate (2013-2018)
6 Europe Orphan Drugs by Countries
6.1 Europe Orphan Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Orphan Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Orphan Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Orphan Drugs Sales and Growth Rate (2013-2018)
6.3 UK Orphan Drugs Sales and Growth Rate (2013-2018)
6.4 France Orphan Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Orphan Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Orphan Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Orphan Drugs by Countries
7.1 Asia-Pacific Orphan Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Orphan Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Orphan Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Orphan Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Orphan Drugs Sales and Growth Rate (2013-2018)
7.5 India Orphan Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018)
8 South America Orphan Drugs by Countries
8.1 South America Orphan Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Orphan Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Orphan Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Orphan Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Orphan Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Orphan Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Orphan Drugs by Countries
9.1 Middle East and Africa Orphan Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Orphan Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Orphan Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Orphan Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Orphan Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Orphan Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Orphan Drugs Sales and Growth Rate (2013-2018)
10 Global Orphan Drugs Market Segment by Type
10.1 Global Orphan Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Orphan Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Orphan Drugs Revenue and Market Share by Type (2013-2018)
10.2 Oncology Sales Growth and Price
10.2.1 Global Oncology Sales Growth (2013-2018)
10.2.2 Global Oncology Price (2013-2018)
10.3 Gastrointestinal Sales Growth and Price
10.3.1 Global Gastrointestinal Sales Growth (2013-2018)
10.3.2 Global Gastrointestinal Price (2013-2018)
10.4 Pulmonary Sales Growth and Price
10.4.1 Global Pulmonary Sales Growth (2013-2018)
10.4.2 Global Pulmonary Price (2013-2018)
10.5 Neurology Sales Growth and Price
10.5.1 Global Neurology Sales Growth (2013-2018)
10.5.2 Global Neurology Price (2013-2018)
10.6 Hematology Sales Growth and Price
10.6.1 Global Hematology Sales Growth (2013-2018)
10.6.2 Global Hematology Price (2013-2018)
10.7 Cardio-vascular Sales Growth and Price
10.7.1 Global Cardio-vascular Sales Growth (2013-2018)
10.7.2 Global Cardio-vascular Price (2013-2018)
10.8 Metabolic disorders Sales Growth and Price
10.8.1 Global Metabolic disorders Sales Growth (2013-2018)
10.8.2 Global Metabolic disorders Price (2013-2018)
10.9 Endocrinology Sales Growth and Price
10.9.1 Global Endocrinology Sales Growth (2013-2018)
10.9.2 Global Endocrinology Price (2013-2018)
10.10 Infectious diseases Sales Growth and Price
10.10.1 Global Infectious diseases Sales Growth (2013-2018)
10.10.2 Global Infectious diseases Price (2013-2018)
10.11 Others Sales Growth and Price
10.11.1 Global Others Sales Growth (2013-2018)
10.11.2 Global Others Price (2013-2018)
11 Global Orphan Drugs Market Segment by Application
11.1 Global Orphan Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Speciality Pharmacies Sales Growth (2013-2018)
11.4 Retail pharmacies Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Orphan Drugs Market Forecast (2018-2023)
12.1 Global Orphan Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Orphan Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Orphan Drugs Market Forecast (2018-2023)
12.2.2 Europe Orphan Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Orphan Drugs Market Forecast (2018-2023)
12.2.4 South America Orphan Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Orphan Drugs Market Forecast (2018-2023)
12.3 Orphan Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Orphan Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Orphan Drugs Market Share Forecast by Type (2018-2023)
12.4 Orphan Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Orphan Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Orphan Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Orphan Drugs Picture
Table Product Specifications of Orphan Drugs
Figure Global Sales Market Share of Orphan Drugs by Types in 2017
Table Orphan Drugs Types for Major Manufacturers
Figure Oncology Picture
Figure Gastrointestinal Picture
Figure Pulmonary Picture
Figure Neurology Picture
Figure Hematology Picture
Figure Cardio-vascular Picture
Figure Metabolic disorders Picture
Figure Endocrinology Picture
Figure Infectious diseases Picture
Figure Others Picture
Figure Orphan Drugs Sales Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Speciality Pharmacies Picture
Figure Retail pharmacies Picture
Figure Others Picture
Figure United States Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Orphan Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Orphan Drugs Type and Applications
Table Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Orphan Drugs Type and Applications
Table Bristol-Myers Squibb Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Orphan Drugs Type and Applications
Table Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Orphan Drugs Type and Applications
Table Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Orphan Drugs Type and Applications
Table Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Orphan Drugs Type and Applications
Table Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Orphan Drugs Type and Applications
Table Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Orphan Drugs Type and Applications
Table Eli Lilly Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Orphan Drugs Type and Applications
Table Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Orphan Drugs Type and Applications
Table AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Orphan Drugs Type and Applications
Table Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Orphan Drugs Type and Applications
Table Daiichi Sankyo Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Orphan Drugs Type and Applications
Table Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Orphan Drugs Type and Applications
Table GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Orphan Drugs Type and Applications
Table Merck Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Orphan Drugs Type and Applications
Table Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Orphan Drugs Type and Applications
Table Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Orphan Drugs Type and Applications
Table Shire Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Orphan Drugs Type and Applications
Table Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Orphan Drugs Sales by Manufacturer (2016-2017)
Figure Global Orphan Drugs Sales Market Share by Manufacturer in 2016
Figure Global Orphan Drugs Sales Market Share by Manufacturer in 2017
Table Global Orphan Drugs Revenue by Manufacturer (2016-2017)
Figure Global Orphan Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Orphan Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Orphan Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Orphan Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Global Orphan Drugs Revenue and Growth Rate (2013-2018)
Table Global Orphan Drugs Sales by Regions (2013-2018)
Table Global Orphan Drugs Sales Market Share by Regions (2013-2018)
Table Global Orphan Drugs Revenue by Regions (2013-2018)
Figure Global Orphan Drugs Revenue Market Share by Regions in 2013
Figure Global Orphan Drugs Revenue Market Share by Regions in 2017
Figure North America Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Europe Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Orphan Drugs Sales and Growth Rate (2013-2018)
Figure South America Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Orphan Drugs Sales and Growth Rate (2013-2018)
Figure North America Orphan Drugs Revenue and Growth Rate (2013-2018)
Table North America Orphan Drugs Sales by Countries (2013-2018)
Table North America Orphan Drugs Sales Market Share by Countries (2013-2018)
Figure North America Orphan Drugs Sales Market Share by Countries in 2013
Figure North America Orphan Drugs Sales Market Share by Countries in 2017
Table North America Orphan Drugs Revenue by Countries (2013-2018)
Table North America Orphan Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Orphan Drugs Revenue Market Share by Countries in 2013
Figure North America Orphan Drugs Revenue Market Share by Countries in 2017
Figure United States Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Canada Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Europe Orphan Drugs Revenue and Growth Rate (2013-2018)
Table Europe Orphan Drugs Sales by Countries (2013-2018)
Table Europe Orphan Drugs Sales Market Share by Countries (2013-2018)
Table Europe Orphan Drugs Revenue by Countries (2013-2018)
Figure Europe Orphan Drugs Revenue Market Share by Countries in 2016
Figure Europe Orphan Drugs Revenue Market Share by Countries in 2017
Figure Germany Orphan Drugs Sales and Growth Rate (2013-2018)
Figure UK Orphan Drugs Sales and Growth Rate (2013-2018)
Figure France Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Russia Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Italy Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Orphan Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Orphan Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Orphan Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Orphan Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Orphan Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Orphan Drugs Revenue Market Share by Countries 2017
Figure China Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Japan Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Korea Orphan Drugs Sales and Growth Rate (2013-2018)
Figure India Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018)
Figure South America Orphan Drugs Revenue and Growth Rate (2013-2018)
Table South America Orphan Drugs Sales by Countries (2013-2018)
Table South America Orphan Drugs Sales Market Share by Countries (2013-2018)
Figure South America Orphan Drugs Sales Market Share by Countries in 2017
Table South America Orphan Drugs Revenue by Countries (2013-2018)
Table South America Orphan Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Orphan Drugs Revenue Market Share by Countries in 2017
Figure Brazil Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Orphan Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Orphan Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Orphan Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Orphan Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Orphan Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Orphan Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Orphan Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Orphan Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018)
Figure UAE Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Orphan Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Orphan Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Orphan Drugs Sales and Growth Rate (2013-2018)
Table Global Orphan Drugs Sales by Type (2013-2018)
Table Global Orphan Drugs Sales Share by Type (2013-2018)
Table Global Orphan Drugs Revenue by Type (2013-2018)
Table Global Orphan Drugs Revenue Share by Type (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Oncology Price (2013-2018)
Figure Global Gastrointestinal Sales Growth (2013-2018)
Figure Global Gastrointestinal Price (2013-2018)
Figure Global Pulmonary Sales Growth (2013-2018)
Figure Global Pulmonary Price (2013-2018)
Figure Global Neurology Sales Growth (2013-2018)
Figure Global Neurology Price (2013-2018)
Figure Global Hematology Sales Growth (2013-2018)
Figure Global Hematology Price (2013-2018)
Figure Global Cardio-vascular Sales Growth (2013-2018)
Figure Global Cardio-vascular Price (2013-2018)
Figure Global Metabolic disorders Sales Growth (2013-2018)
Figure Global Metabolic disorders Price (2013-2018)
Figure Global Endocrinology Sales Growth (2013-2018)
Figure Global Endocrinology Price (2013-2018)
Figure Global Infectious diseases Sales Growth (2013-2018)
Figure Global Infectious diseases Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Orphan Drugs Sales by Application (2013-2018)
Table Global Orphan Drugs Sales Share by Application (2013-2018)
Figure Global Speciality Pharmacies Sales Growth (2013-2018)
Figure Global Retail pharmacies Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Orphan Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Orphan Drugs Sales Forecast by Regions (2018-2023)
Table Global Orphan Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Orphan Drugs Market Forecast (2018-2023)
Figure Europe Sales Orphan Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Orphan Drugs Market Forecast (2018-2023)
Figure South America Sales Orphan Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Orphan Drugs Market Forecast (2018-2023)
Table Global Orphan Drugs Sales Forecast by Type (2018-2023)
Table Global Orphan Drugs Market Share Forecast by Type (2018-2023)
Table Global Orphan Drugs Sales Forecast by Application (2018-2023)
Table Global Orphan Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Botulinum Toxin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 113
    Botulinum toxin (BTX) or Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. Scope of the Report: This report focuses on the Botulinum Toxin in glo......
  • Global Brain Health Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Brain health supplements are used to enhance memory, attention, mood, creativity, motivation in healthy individuals. Increasing awareness among college students, scientists, entrepreneurs and investment bankers are opting for memory enhancers to sharpen their minds to gain an edge on the competition. Scope of the Report: This report focuses on the Brain Health Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle E......
  • Global Morphine Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 113
    Morphine is a pain medication of the opiate family which is found naturally in a number of plants and animals. As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine. The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief p......
  • Global Levofloxacin Market Insights, Forecast to 2025
    Published: 19-Oct-2018        Price: US 3900 Onwards        Pages: 116
    Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form. Factors such as increasing incidences of bacterial inf......
  • Global Tamoxifen Citrate Market Research Report 2018
    Published: 19-Oct-2018        Price: US 2900 Onwards        Pages: 115
    This report studies the global Tamoxifen Citrate market status and forecast, categorizes the global Tamoxifen Citrate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Cayman Chemical Company - Agvar Chemicals Inc - Cayman Chemical Company......
  • Global Bioengineered Protein Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Scope of the Report: This report focuses on the Bioengineered Protein Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products ......
  • Global Minocycline Hydrochloride Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Minocycline Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Minocycline Hydrochloride in these regions. This research report categorizes the global Minocycline Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global and United States Opioid-induced Constipation Market Research by Company, Type & Application 2013-2025
    Published: 18-Oct-2018        Price: US 2000 Onwards        Pages: 109
    Summary Market Segment as follows: By Type - Solid - Liquid By Application - Drugstore - Hospital - Others By Company - AstraZeneca - Takeda Pharmaceutical - Valeant Pharmaceuticals International - Abbott - Bayer - Boehringer Ingelheim - C.B. Fleet - Cosmo Pharmaceuticals - Daewoong - Daiichi Sankyo - GlaxoSmithKline - Ironwoo......
  • Global Budesonide Sprays Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 125
    In 2017, the global Budesonide Sprays market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Budesonide Sprays market based on company, product type, application and key regions. This report studies the global market size of Budesonide Sprays in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs